LFs were also related to the presence of ccRCC somatic cancer driver mutations, of which associations with PBRM1, SETD2, BAP1, and TP53 were replicated in the validation phase (Figs. 2C and EV3C). The gene discussed is BAP1; the disease is nonpapillary renal cell carcinoma.